Haloperidol i.m

The mean haloperidol dose was mg (median 10 mg, range 4-20 mg). The mean droperidol dose was mg (median mg, range -10 mg.) Haloperidol was given . in 289 cases (92%), and droperidol was given . in 132 cases (61%); in all other cases, the medication was given .. There was no statistically significant difference in median QTc after medication administration (haloperidol 447 ms, 95% CI: 440-454 ms; droperidol 454 ms, 95% CI: 450-457). There were no statistically significant differences in adverse events in the droperidol group as compared to the haloperidol group. One patient in the droperidol group with a history of congenital heart disease suffered a cardiopulmonary arrest and was resuscitated with neurologically intact survival. There was no significant difference in the use of additional sedating medications within 30 minutes of ED arrival after receiving droperidol (%, 95% CI: --%).

Nausea is an uneasiness of the stomach that often precedes vomiting. Nausea and vomiting are not diseases, but they are symptoms of many conditions. There are numerous cases of nausea and vomiting. Some causes may not require medical treatment, for example, motion sickness, and other causes may require medical treatment by a doctor, for example, heart attack, lung infections, bronchitis, and pneumonia.

Some causes of nausea and vomiting may be life threatening, for example, heart attack, abdominal obstruction, and cancers.

Treatment of nausea and vomiting depends upon the cause.

Haloperidol i.m

haloperidol i.m


haloperidol i.mhaloperidol i.mhaloperidol i.mhaloperidol i.mhaloperidol i.m